Request for Covid-19 Impact Assessment of this Report
The United States Geographic Atrophy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Geographic Atrophy market, reaching US$ million by the year 2028. As for the Europe Geographic Atrophy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Geographic Atrophy players cover Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, and Hemera Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Above 60 Years
Above 75 Years
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Late-stage (Phase III)
Phase II
Phase I
Pre-clinical stage
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Apellis Pharmaceuticals
Iveric Bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche
Gensight Biologics
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Geographic Atrophy Market Size 2017-2028
2.1.2 Geographic Atrophy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Geographic Atrophy Segment by Type
2.2.1 Above 60 Years
2.2.2 Above 75 Years
2.3 Geographic Atrophy Market Size by Type
2.3.1 Geographic Atrophy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Geographic Atrophy Market Size Market Share by Type (2017-2022)
2.4 Geographic Atrophy Segment by Application
2.4.1 Late-stage (Phase III)
2.4.2 Phase II
2.4.3 Phase I
2.4.4 Pre-clinical stage
2.5 Geographic Atrophy Market Size by Application
2.5.1 Geographic Atrophy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Geographic Atrophy Market Size Market Share by Application (2017-2022)
3 Geographic Atrophy Market Size by Player
3.1 Geographic Atrophy Market Size Market Share by Players
3.1.1 Global Geographic Atrophy Revenue by Players (2020-2022)
3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2020-2022)
3.2 Global Geographic Atrophy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Geographic Atrophy by Regions
4.1 Geographic Atrophy Market Size by Regions (2017-2022)
4.2 Americas Geographic Atrophy Market Size Growth (2017-2022)
4.3 APAC Geographic Atrophy Market Size Growth (2017-2022)
4.4 Europe Geographic Atrophy Market Size Growth (2017-2022)
4.5 Middle East & Africa Geographic Atrophy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Geographic Atrophy Market Size by Country (2017-2022)
5.2 Americas Geographic Atrophy Market Size by Type (2017-2022)
5.3 Americas Geographic Atrophy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Geographic Atrophy Market Size by Region (2017-2022)
6.2 APAC Geographic Atrophy Market Size by Type (2017-2022)
6.3 APAC Geographic Atrophy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Geographic Atrophy by Country (2017-2022)
7.2 Europe Geographic Atrophy Market Size by Type (2017-2022)
7.3 Europe Geographic Atrophy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Geographic Atrophy by Region (2017-2022)
8.2 Middle East & Africa Geographic Atrophy Market Size by Type (2017-2022)
8.3 Middle East & Africa Geographic Atrophy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Geographic Atrophy Market Forecast
10.1 Global Geographic Atrophy Forecast by Regions (2023-2028)
10.1.1 Global Geographic Atrophy Forecast by Regions (2023-2028)
10.1.2 Americas Geographic Atrophy Forecast
10.1.3 APAC Geographic Atrophy Forecast
10.1.4 Europe Geographic Atrophy Forecast
10.1.5 Middle East & Africa Geographic Atrophy Forecast
10.2 Americas Geographic Atrophy Forecast by Country (2023-2028)
10.2.1 United States Geographic Atrophy Market Forecast
10.2.2 Canada Geographic Atrophy Market Forecast
10.2.3 Mexico Geographic Atrophy Market Forecast
10.2.4 Brazil Geographic Atrophy Market Forecast
10.3 APAC Geographic Atrophy Forecast by Region (2023-2028)
10.3.1 China Geographic Atrophy Market Forecast
10.3.2 Japan Geographic Atrophy Market Forecast
10.3.3 Korea Geographic Atrophy Market Forecast
10.3.4 Southeast Asia Geographic Atrophy Market Forecast
10.3.5 India Geographic Atrophy Market Forecast
10.3.6 Australia Geographic Atrophy Market Forecast
10.4 Europe Geographic Atrophy Forecast by Country (2023-2028)
10.4.1 Germany Geographic Atrophy Market Forecast
10.4.2 France Geographic Atrophy Market Forecast
10.4.3 UK Geographic Atrophy Market Forecast
10.4.4 Italy Geographic Atrophy Market Forecast
10.4.5 Russia Geographic Atrophy Market Forecast
10.5 Middle East & Africa Geographic Atrophy Forecast by Region (2023-2028)
10.5.1 Egypt Geographic Atrophy Market Forecast
10.5.2 South Africa Geographic Atrophy Market Forecast
10.5.3 Israel Geographic Atrophy Market Forecast
10.5.4 Turkey Geographic Atrophy Market Forecast
10.5.5 GCC Countries Geographic Atrophy Market Forecast
10.6 Global Geographic Atrophy Forecast by Type (2023-2028)
10.7 Global Geographic Atrophy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Information
11.1.2 Apellis Pharmaceuticals Geographic Atrophy Product Offered
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Apellis Pharmaceuticals Main Business Overview
11.1.5 Apellis Pharmaceuticals Latest Developments
11.2 Iveric Bio
11.2.1 Iveric Bio Company Information
11.2.2 Iveric Bio Geographic Atrophy Product Offered
11.2.3 Iveric Bio Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Iveric Bio Main Business Overview
11.2.5 Iveric Bio Latest Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Information
11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Product Offered
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Alkeus Pharmaceuticals Main Business Overview
11.3.5 Alkeus Pharmaceuticals Latest Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Information
11.4.2 Hemera Biosciences Geographic Atrophy Product Offered
11.4.3 Hemera Biosciences Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Hemera Biosciences Main Business Overview
11.4.5 Hemera Biosciences Latest Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Information
11.5.2 Allegro Ophthalmics Geographic Atrophy Product Offered
11.5.3 Allegro Ophthalmics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Allegro Ophthalmics Main Business Overview
11.5.5 Allegro Ophthalmics Latest Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Information
11.6.2 Stealth BioTherapeutics Geographic Atrophy Product Offered
11.6.3 Stealth BioTherapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Stealth BioTherapeutics Main Business Overview
11.6.5 Stealth BioTherapeutics Latest Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Information
11.7.2 Gyroscope Therapeutics Geographic Atrophy Product Offered
11.7.3 Gyroscope Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Gyroscope Therapeutics Main Business Overview
11.7.5 Gyroscope Therapeutics Latest Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Information
11.8.2 Regenerative Patch Technologies Geographic Atrophy Product Offered
11.8.3 Regenerative Patch Technologies Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Regenerative Patch Technologies Main Business Overview
11.8.5 Regenerative Patch Technologies Latest Developments
11.9 Roche
11.9.1 Roche Company Information
11.9.2 Roche Geographic Atrophy Product Offered
11.9.3 Roche Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Roche Main Business Overview
11.9.5 Roche Latest Developments
11.10 Gensight Biologics
11.10.1 Gensight Biologics Company Information
11.10.2 Gensight Biologics Geographic Atrophy Product Offered
11.10.3 Gensight Biologics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Gensight Biologics Main Business Overview
11.10.5 Gensight Biologics Latest Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Information
11.11.2 NGM Biopharmaceuticals Geographic Atrophy Product Offered
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 NGM Biopharmaceuticals Main Business Overview
11.11.5 NGM Biopharmaceuticals Latest Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Information
11.12.2 AstraZeneca Geographic Atrophy Product Offered
11.12.3 AstraZeneca Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 AstraZeneca Main Business Overview
11.12.5 AstraZeneca Latest Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Information
11.13.2 Lineage Cell Therapeutics Geographic Atrophy Product Offered
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Lineage Cell Therapeutics Main Business Overview
11.13.5 Lineage Cell Therapeutics Latest Developments
11.14 Allergan
11.14.1 Allergan Company Information
11.14.2 Allergan Geographic Atrophy Product Offered
11.14.3 Allergan Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Allergan Main Business Overview
11.14.5 Allergan Latest Developments
12 Research Findings and Conclusion
Table 1. Geographic Atrophy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Above 60 Years
Table 3. Major Players of Above 75 Years
Table 4. Geographic Atrophy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Geographic Atrophy Market Size Market Share by Type (2017-2022)
Table 7. Geographic Atrophy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Geographic Atrophy Market Size Market Share by Application (2017-2022)
Table 10. Global Geographic Atrophy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Geographic Atrophy Revenue Market Share by Player (2020-2022)
Table 12. Geographic Atrophy Key Players Head office and Products Offered
Table 13. Geographic Atrophy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Geographic Atrophy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Geographic Atrophy Market Size Market Share by Regions (2017-2022)
Table 18. Americas Geographic Atrophy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Geographic Atrophy Market Size Market Share by Country (2017-2022)
Table 20. Americas Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Geographic Atrophy Market Size Market Share by Type (2017-2022)
Table 22. Americas Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Geographic Atrophy Market Size Market Share by Application (2017-2022)
Table 24. APAC Geographic Atrophy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Geographic Atrophy Market Size Market Share by Region (2017-2022)
Table 26. APAC Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Geographic Atrophy Market Size Market Share by Type (2017-2022)
Table 28. APAC Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Geographic Atrophy Market Size Market Share by Application (2017-2022)
Table 30. Europe Geographic Atrophy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Geographic Atrophy Market Size Market Share by Country (2017-2022)
Table 32. Europe Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Geographic Atrophy Market Size Market Share by Type (2017-2022)
Table 34. Europe Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Geographic Atrophy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Geographic Atrophy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Geographic Atrophy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Geographic Atrophy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Geographic Atrophy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Geographic Atrophy
Table 43. Key Market Challenges & Risks of Geographic Atrophy
Table 44. Key Industry Trends of Geographic Atrophy
Table 45. Global Geographic Atrophy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Geographic Atrophy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Geographic Atrophy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Geographic Atrophy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Geographic Atrophy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Geographic Atrophy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Apellis Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 52. Apellis Pharmaceuticals Geographic Atrophy Product Offered
Table 53. Apellis Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Apellis Pharmaceuticals Main Business
Table 55. Apellis Pharmaceuticals Latest Developments
Table 56. Iveric Bio Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 57. Iveric Bio Geographic Atrophy Product Offered
Table 58. Iveric Bio Main Business
Table 59. Iveric Bio Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Iveric Bio Latest Developments
Table 61. Alkeus Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 62. Alkeus Pharmaceuticals Geographic Atrophy Product Offered
Table 63. Alkeus Pharmaceuticals Main Business
Table 64. Alkeus Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Alkeus Pharmaceuticals Latest Developments
Table 66. Hemera Biosciences Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 67. Hemera Biosciences Geographic Atrophy Product Offered
Table 68. Hemera Biosciences Main Business
Table 69. Hemera Biosciences Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Hemera Biosciences Latest Developments
Table 71. Allegro Ophthalmics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 72. Allegro Ophthalmics Geographic Atrophy Product Offered
Table 73. Allegro Ophthalmics Main Business
Table 74. Allegro Ophthalmics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Allegro Ophthalmics Latest Developments
Table 76. Stealth BioTherapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 77. Stealth BioTherapeutics Geographic Atrophy Product Offered
Table 78. Stealth BioTherapeutics Main Business
Table 79. Stealth BioTherapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Stealth BioTherapeutics Latest Developments
Table 81. Gyroscope Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 82. Gyroscope Therapeutics Geographic Atrophy Product Offered
Table 83. Gyroscope Therapeutics Main Business
Table 84. Gyroscope Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Gyroscope Therapeutics Latest Developments
Table 86. Regenerative Patch Technologies Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 87. Regenerative Patch Technologies Geographic Atrophy Product Offered
Table 88. Regenerative Patch Technologies Main Business
Table 89. Regenerative Patch Technologies Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Regenerative Patch Technologies Latest Developments
Table 91. Roche Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 92. Roche Geographic Atrophy Product Offered
Table 93. Roche Main Business
Table 94. Roche Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Roche Latest Developments
Table 96. Gensight Biologics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 97. Gensight Biologics Geographic Atrophy Product Offered
Table 98. Gensight Biologics Main Business
Table 99. Gensight Biologics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Gensight Biologics Latest Developments
Table 101. NGM Biopharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 102. NGM Biopharmaceuticals Geographic Atrophy Product Offered
Table 103. NGM Biopharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. NGM Biopharmaceuticals Main Business
Table 105. NGM Biopharmaceuticals Latest Developments
Table 106. AstraZeneca Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 107. AstraZeneca Geographic Atrophy Product Offered
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. AstraZeneca Latest Developments
Table 111. Lineage Cell Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 112. Lineage Cell Therapeutics Geographic Atrophy Product Offered
Table 113. Lineage Cell Therapeutics Main Business
Table 114. Lineage Cell Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Lineage Cell Therapeutics Latest Developments
Table 116. Allergan Details, Company Type, Geographic Atrophy Area Served and Its Competitors
Table 117. Allergan Geographic Atrophy Product Offered
Table 118. Allergan Main Business
Table 119. Allergan Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Allergan Latest Developments
List of Figures
Figure 1. Geographic Atrophy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Geographic Atrophy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Geographic Atrophy Market Size Market Share by Type in 2021
Figure 7. Geographic Atrophy in Late-stage (Phase III)
Figure 8. Global Geographic Atrophy Market: Late-stage (Phase III) (2017-2022) & ($ Millions)
Figure 9. Geographic Atrophy in Phase II
Figure 10. Global Geographic Atrophy Market: Phase II (2017-2022) & ($ Millions)
Figure 11. Geographic Atrophy in Phase I
Figure 12. Global Geographic Atrophy Market: Phase I (2017-2022) & ($ Millions)
Figure 13. Geographic Atrophy in Pre-clinical stage
Figure 14. Global Geographic Atrophy Market: Pre-clinical stage (2017-2022) & ($ Millions)
Figure 15. Global Geographic Atrophy Market Size Market Share by Application in 2021
Figure 16. Global Geographic Atrophy Revenue Market Share by Player in 2021
Figure 17. Global Geographic Atrophy Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Geographic Atrophy Market Size 2017-2022 ($ Millions)
Figure 19. APAC Geographic Atrophy Market Size 2017-2022 ($ Millions)
Figure 20. Europe Geographic Atrophy Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Geographic Atrophy Market Size 2017-2022 ($ Millions)
Figure 22. Americas Geographic Atrophy Value Market Share by Country in 2021
Figure 23. Americas Geographic Atrophy Consumption Market Share by Type in 2021
Figure 24. Americas Geographic Atrophy Market Size Market Share by Application in 2021
Figure 25. United States Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Geographic Atrophy Market Size Market Share by Region in 2021
Figure 30. APAC Geographic Atrophy Market Size Market Share by Application in 2021
Figure 31. China Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Geographic Atrophy Market Size Market Share by Country in 2021
Figure 38. Europe Geographic Atrophy Market Size Market Share by Type in 2021
Figure 39. Europe Geographic Atrophy Market Size Market Share by Application in 2021
Figure 40. Germany Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Geographic Atrophy Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Geographic Atrophy Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Geographic Atrophy Market Size Market Share by Application in 2021
Figure 48. Egypt Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 54. APAC Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 55. Europe Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 57. United States Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 58. Canada Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 61. China Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 62. Japan Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 63. Korea Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 65. India Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 66. Australia Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 67. Germany Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 68. France Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 69. UK Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 70. Italy Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 71. Russia Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 72. Spain Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 75. Israel Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Geographic Atrophy Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Geographic Atrophy Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...